Presentation topic: Discovery of Gene-Based Drugs
The cost of discovery, development, and marketing of new drugs has
increased dramatically. At 20% of revenue, over 30 billion dollars is
spent annually on drug discovery and development. These funds are spent
on a complex process that can span as much as 15 years and $800 million
dollars for a single drug. New discoveries in genomics and proteomics
provide ample opportunity for the discovery of new drug targets early in
the process. The presentation is an introduction of what new
technologies are available and how to use them to discover biomarkers,
disease genes and signaling pathway for developing of gene-based drugs
and personalized medications.
Biography:
Dr. Wan-Heng Wang is a molecular biologist working for Alcon Research
Ltd., an eye-care pharmaceutical company located in Fort Worth. Dr.
Wang's education has been international. He finished his regular school
education in China, received his Ph.D. degree at Tokyo University in
Japan and had his postdoctoral training at Stanford University in the
US. Currently, as a Principle Scientist of the company he is focusing
on discovery of therapeutic targets for treating glaucoma using
cutting-edge new approaches such as microarray and nano-technologies.
Chinese Announcement
To register for a CIE/USA-DFW Event (Bio Tech seminar - Discovery of Gene-Based Drugs) ---->
CIE/USA-DFW Event Registration
2006 Bio-Tech Seminar -- Discovery of Gene-Based Drugs